Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Peringkat dalam Saham #33388
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Harga Saham
$5.34
Kapitalisasi Pasar
$7.80M
Perubahan (1 hari)
-3.26%
Perubahan (1 tahun)
4.91%
Negara
US
Perdagangan CNS Pharmaceuticals, Inc. (CNSP)

Kategori

Riwayat pemecahan saham untuk CNS Pharmaceuticals, Inc. (CNSP)
Saham CNS Pharmaceuticals, Inc. (simbol: CNSP) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 17, 2026.
Satu lembar saham CNSP yang dibeli sebelum Aug 17, 2026 sekarang setara dengan 0 lembar saham CNSP.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE